Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

MLA

Shahrin, Lubaba, et al. “Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial.” JMIR Research Protocols, vol. 9, no. 11, Nov. 2020, p. e17735. EBSCOhost, https://doi.org/10.2196/17735.

APA

Shahrin, L., Chisti, M. J., Shahid, A. S. M. S. B., Rahman, A. S. M. M. H., Islam, M. Z., Afroze, F., Huq, S., & Ahmed, T. (2020). Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial. JMIR Research Protocols, 9(11), e17735. https://doi.org/10.2196/17735

Chicago

Shahrin, Lubaba, Mohammod Jobayer Chisti, Abu Sadat Mohammad Sayeem Bin Shahid, Abu Sayem Mirza Mohammad Hasibur Rahman, Md. Zahidul Islam, Farzana Afroze, Sayeeda Huq, and Tahmeed Ahmed. 2020. “Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial.” JMIR Research Protocols 9 (11): e17735. doi:10.2196/17735.